Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry | Aplastic Anemia and MDS International Foundation

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry

Journal Title: 
Leukemia
Author(s): 
Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Jongen-Lavrencic M
Primary Author: 
Dinmohamed AG
Original Publication Date: 
Tuesday, September 15, 2015

No abstract available.

Bone Marrow Diseases: